2026-09-24T12:33:27-04:00 2025-12-31 461335331 ALTRUIC ADVISORS CPAS 417 FOREST AVENUE PLYMOUTH MI 48170 990 2025-01-01 208735688 SOLVING KIDS' CANCER INC SOLV 2125886624 1 EAST 53RD STREET 8TH FLOOR NEW YORK NY 10022 EYAL SOFFER TREASURER 2125886624 2026-09-21 true RYAN N HAGAN CPA P00293011 8882985297 2026-09-21 2025 EYAL SOFFER 1 EAST 53RD STREET 8TH FLOOR NEW YORK NY 10022 649414 false X WWW.SOLVINGKIDSCANCER.ORG X 2006 NY SOLVING KIDS' CANCER FINDS, FUNDS, AND ADVOCATES FOR BREAKTHROUGH TREATMENT OPTIONS TO IMPROVE SURVIVAL OUTCOMES FOR CHILDREN WITH THE MOST FATAL PEDIATRIC CANCERS. 13 13 3 14 0 274038 600911 0 70757 39278 -11394 -25055 333401 615134 331876 0 352724 183614 70940 43507 120110 225559 92282 649223 651279 -315822 -36145 1755507 1686816 141673 109127 1613834 1577689 X SKC IMPACTS CHILDREN THROUGH THE INITIATION OF CLINICAL RESEARCH TRIALS OF INVESTIGATIVE TREATMENT STRATEGIES. OUR VISION IS TO CONTINUE EXPANDING THE ARMAMENTARIUM OF EFFECTIVE AND LESS TOXIC TREARTMENT STRATEGIES FOR PEDIATRIC ONCOLOGISTCS TO UTILIZE, UNTIL LONG-TERM SURVIVAL IS A REALITY FORVALL CHILDREN WITH HIGH-RISK SOLID TUMORS AND BRAIN TUMORS. TO ACCOMPLISH OUR MISSION, SKC FUNDS AND ADVOCATES FOR BREAKTHROUGH TREATMENT OPTIONS TO IMPROVE SURVIVAL OUTCOMES FOR CHILDREN WITH THE MOST FATAL PEDIATRIC CANCERS THROUGH COLLABORATIVE PARTNERSHIPS WITH THE RESEARCH COMMUNITY AND RELATED NONPROFIT STAKEHOLDERS. false false 453128 331876 SKC LEADERSHIP AND SCIENTIFIC ADVISORS SURVEY, DISCUSS, AND PRIORITIZE THE AREAS OF GREATEST UNMET NEEDS WITHIN THE PEDIATRIC CANCER RESEARCH LANDSCAPE AND DEVELOP SPECIFIC PROGRAMS TO ADDRESS THEM. (1) SKC CONCEIVED AND ORGANIZED THE 2025 CARE FOR RARE GLOBAL STRATEGY FORUM, INVITING THE WORLD'S TOP EXPERTS IN EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES (ETMR) AND ATYPICAL TERATOID RHABDOID TUMOR (ATRT), TWO RARE AND AGGRESSIVE BRAIN TUMORS THAT AFFECT VERY YOUNG CHILDREN. THE OBJECTIVES OF THE MEETING WERE TO FACILITATE THE EXCHANGE OF INFORMATION AROUND EXISTING RESEARCH PROJECTS AND BUILD COLLABORATIONS ACROSS CONTINENTS. (2) SKC ISSUED A CALL FOR PROPOSALS AS A RESULT OF THE CARE FOR RARE STRATEGY FORUM AND AWARDED 600,000 IN COLLABORATION WITH PARTNER CHARITIES TO FUND THREE PROMISING PRE-CLINICAL PROJECTS TO ADVANCE TREATMENT OPTIONS FOR ETMR AND ATRT TUMOR TYPES. (3) SKC HAS ADVISORY ROLES ON NATIONAL AND INTERNATIONAL CLINICAL TRIALS CONSORTIA, REGULATORY BODIES, MULTI STAKEHOLDER PLATFORM FOR PEDIATRIC CANCER DRUG DEVELOPMENT, PHARMACEUTICAL COMPANIES, AND BUILDS COLLABORATIONS WITH OTHER NONPROFITS TO ADVOCATE FOR AND FUND RESEARCH. SKC REVIEWS PROPOSALS FOR THE NCI FUNDED CHILDREN'S ONCOLOGY GROUP AND THE DEPARTMENT OF DEFENSE RARE CANCER RESEARCH PROGRAMMATIC PANEL. SKC WAS INVITED TO SERVE ON PANELS AND PRESENT AT SEVEN SCIENTIFIC MEETINGS IN FIVE COUNTRIES. SKC CO-AUTHORED SEVERAL PEER-REVIEWED JOURNAL ARTICLES AND PEDIATRIC ONCOLOGY TEXTBOOK CHAPTERS. THESE ROLES GIVE SKC OPPORTUNITY TO INFLUENCE RESEARCH AGENDAS AND PRIORITIES. 453128 true true false false false false false false false false true false false true true false true false false false false true false true true false false true false false false false false false false false false false false false false false false true false false false true 5 0 3 true false false false false false true true false false false false false false X 13 13 false false false false false false false true true false false true true true true true true true true false NY X THE ORGANIZATION 2125886624 1 EAST 53RD STREET 8TH FLOOR NEW YORK NY 10022 KRISTI MCKAY EXECUTIVE DI 40.00 X 90612 0 3392 MARK SAVOYE CO-CHAIR 2.00 X X 0 0 0 CHANNING STAVE CO-CHAIR 2.00 X X 0 0 0 MICHELE ALEXANDER CO-SECRETARY 2.00 X X 0 0 0 CATHERINE MURCHIE CO-SECRETARY 2.00 X X 0 0 0 EYAL SOFFER TREASURER 2.00 X X 0 0 0 HEARN JAY CHO DIRECTOR 2.00 X 0 0 0 LINDY GAD DIRECTOR 2.00 X 0 0 0 JOHN LONDON DIRECTOR 2.00 X 0 0 0 MICHAEL NIEDZIELSKI DIRECTOR 2.00 X 0 0 0 CATHERINE LONDON DIRECTOR 2.00 X 0 0 0 DEBORAH HUGHES DIRECTOR 2.00 X 0 0 0 CINDY CAMPBELL DIRECTOR 2.00 X 0 0 0 JAN PLANIT DIRECTOR 2.00 X 0 0 0 90612 3392 false false false 55104 105764 440043 600911 39278 39278 9225 55104 34280 -25055 615134 39278 287476 287476 44400 44400 91000 45500 45500 72683 59584 13095 4 7468 4795 597 2076 12463 8001 997 3465 27920 27920 43507 43507 7775 3775 4000 953 953 813 453 360 8049 2746 5303 19429 19429 3979 3072 431 476 1979 1979 6405 6405 DUES AND FEES 6495 300 6195 BANK AND SERVICE CHARGES 5514 214 5300 DIRECT FUNDRAISING EXP 2971 2971 651279 453128 78041 120110 613695 496909 1002545 1069673 7642 5665 5818 5692 5938 1979 5938 3959 119869 104918 1755507 1686816 23272 5677 118401 103450 141673 109127 X 250033 527793 1363801 1049896 1613834 1577689 1755507 1686816 X -36145 X false true X true false X 691649 970445 657576 274038 600911 3194619 691649 970445 657576 274038 600911 3194619 88628 3105991 7113 25663 71862 70757 39278 214673 3409292 159334 0.91100 0.92490 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 5938 1979 3959 3959 OPERATING LEASE ROU 103450 SECURITY DEPOSITS 1468 104918 OPERATING LEASE LIABILITY 103450 103450 568857 -46277 -46277 615134 615134 605002 -46277 -46277 651279 651279 SCHEDULE D, PAGE 4, PART XI, LINE 2D RETURN OF GRANT FUNDS -46,277 SCHEDULE D, PAGE 4, PART XII, LINE 2D RETURN OF GRANT FUNDS -46,277 EUROPE CANCER RESEARCH 37500 WIRE TRANSFER CANADA CANCER RESEARCH 6900 WIRE TRANSFER 2 2 false false false false false false X X X true STREETLIGHT DIGITAL 13396 LAFAYETTE WAY THORNTON CO 80241 FUNDRAISIN false 60136 36382 23754 60136 36382 23754 HAMPTONS LUNCHE 33445 28270 5175 13787 FALL FETE DINNE 22954 21654 1300 11366 1 7930 5180 2750 9127 64329 55104 9225 34280 34280 -25055 true CHILDREN'S HOSPITAL OF PHILADELPHIA 3401 CIVIC CENTER BLVD PHILADELPHIA PA 19104 231352166 501C3 58214 CANCER RESEARCH NATIONAL CANCER INSTITUTE 9000 ROCKVILLE PIKE BETHESDA MD 20814 131919715 GOV 50000 CANCER RESEARCH VARIOUS ORGANIZATIONS 7455 CANCER RESEARCH TY LOUIS CAMPBELL FOUNDATION 1787 ROUTE 6 CARMEL NY 10512 451858390 501C3 50000 CANCER RESEARCH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA IRVINE 324 ALDRICH HALL IRVINE CA 92697 952226406 501C3 50000 CANCER RESEARCH THE REGENTS OF THE UNIVERSITY OF COLORADO 1800 GRANT STREET STE 200 DENVER CO 80203 846000555 501C3 35000 CANCER RESEARCH JOHNS HOPKINS UNIVERSITY 3910 KESWICK RD N4327B BALTIMORE MD 21211 520595110 501C3 34807 CANCER RESEARCH 6 4 SCHEDULE I, PAGE 1, PART I, LINE 2 THE ORGANIZATION EXPENDS FUNDS IN CONNECTION WITH GRANT COMMITMENTS AS EACH GRANTEE ACCOMPLISHES SPECIFIC MILESTONES SET FORTH IN EACH GRANT AGREEMENT. EACH GRANTEE IS REQUIRED TO SUBMIT PROGRESS REPORTS ON A PERIODIC BASIS AS MILESTONES ARE ACHIEVED PURSUANT TO THE GRANT AGREEMENTS. IF FUNDS ARE NOT USED BY THE GRANTEE IN ACCORDANCE WITH THE AGREEMENT, FUNDS ARE RETURNED. FORM 990 - ORGANIZATION'S MISSION SKC IMPACTS CHILDREN THROUGH THE INITIATION OF CLINICAL RESEARCH TRIALS OF INVESTIGATIVE TREATMENT STRATEGIES. OUR VISION IS TO CONTINUE EXPANDING THE ARMAMENTARIUM OF EFFECTIVE AND LESS TOXIC TREARTMENT STRATEGIES FOR PEDIATRIC ONCOLOGISTCS TO UTILIZE, UNTIL LONG-TERM SURVIVAL IS A REALITY FORVALL CHILDREN WITH HIGH-RISK SOLID TUMORS AND BRAIN TUMORS. TO ACCOMPLISH OUR MISSION, SKC FUNDS AND ADVOCATES FOR BREAKTHROUGH TREATMENT OPTIONS TO IMPROVE SURVIVAL OUTCOMES FOR CHILDREN WITH THE MOST FATAL PEDIATRIC CANCERS THROUGH COLLABORATIVE PARTNERSHIPS WITH THE RESEARCH COMMUNITY AND RELATED NONPROFIT STAKEHOLDERS. FORM 990, PAGE 2, PART III, LINE 4A SKC LEADERSHIP AND SCIENTIFIC ADVISORS SURVEY, DISCUSS, AND PRIORITIZE THE AREAS OF GREATEST UNMET NEEDS WITHIN THE PEDIATRIC CANCER RESEARCH LANDSCAPE AND DEVELOP SPECIFIC PROGRAMS TO ADDRESS THEM. (1) SKC CONCEIVED AND ORGANIZED THE 2025 CARE FOR RARE GLOBAL STRATEGY FORUM, INVITING THE WORLD'S TOP EXPERTS IN EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES (ETMR) AND ATYPICAL TERATOID RHABDOID TUMOR (ATRT), TWO RARE AND AGGRESSIVE BRAIN TUMORS THAT AFFECT VERY YOUNG CHILDREN. THE OBJECTIVES OF THE MEETING WERE TO FACILITATE THE EXCHANGE OF INFORMATION AROUND EXISTING RESEARCH PROJECTS AND BUILD COLLABORATIONS ACROSS CONTINENTS. (2) SKC ISSUED A CALL FOR PROPOSALS AS A RESULT OF THE CARE FOR RARE STRATEGY FORUM AND AWARDED 600,000 IN COLLABORATION WITH PARTNER CHARITIES TO FUND THREE PROMISING PRE-CLINICAL PROJECTS TO ADVANCE TREATMENT OPTIONS FOR ETMR AND ATRT TUMOR TYPES. (3) SKC HAS ADVISORY ROLES ON NATIONAL AND INTERNATIONAL CLINICAL TRIALS CONSORTIA, REGULATORY BODIES, MULTI STAKEHOLDER PLATFORM FOR PEDIATRIC CANCER DRUG DEVELOPMENT, PHARMACEUTICAL COMPANIES, AND BUILDS COLLABORATIONS WITH OTHER NONPROFITS TO ADVOCATE FOR AND FUND RESEARCH. SKC REVIEWS PROPOSALS FOR THE NCI FUNDED CHILDREN'S ONCOLOGY GROUP AND THE DEPARTMENT OF DEFENSE RARE CANCER RESEARCH PROGRAMMATIC PANEL. SKC WAS INVITED TO SERVE ON PANELS AND PRESENT AT SEVEN SCIENTIFIC MEETINGS IN FIVE COUNTRIES. SKC CO-AUTHORED SEVERAL PEER-REVIEWED JOURNAL ARTICLES AND PEDIATRIC ONCOLOGY TEXTBOOK CHAPTERS. THESE ROLES GIVE SKC OPPORTUNITY TO INFLUENCE RESEARCH AGENDAS AND PRIORITIES. FORM 990, PAGE 6, PART VI, LINE 11B THE COMPLETED FORM 990 IS SENT TO THE BOARD OF DIRECTORS FOR REVIEW AND APPROVAL PRIOR TO FILING. FORM 990, PAGE 6, PART VI, LINE 12C THE ORGANIZATION DISTRIBUTES A CONFLICT OF INTEREST POLICY TO EACH BOARD MEMBER ANNUALLY AT THE BOARD MEETING. ALL STAFF AND BOARD MEMBERS ARE REQUIRED TO SIGN A CONFLICT OF INTEREST POLICY STATEMENT. ANY CONFLICTS THAT ARISE DURING THE COURSE OF THE YEAR ARE REQUIRED TO BE DISCLOSED AND RESOLVED BEFORE THE TRANSACTION IS COMPLETED. FORM 990, PAGE 6, PART VI, LINE 15A COMPENSATION IS DETERMINED BY CONDUCTING A FAIR MARKET VALUE COMPARISON OF OTHER ORGANIZATIONS BY THE BOARD CHAIR. FACTORS INCLUDE THE NUMBER OF HOURS WORKED AND THE BREADTH OF ROLES AND RESPONSIBILITIES. FORM 990, PAGE 6, PART VI, LINE 15B COMPENSATION IS DETERMINED BY CONDUCTING A FAIR MARKET VALUE COMPARISON OF OTHER ORGANIZATIONS BY THE BOARD CHAIR. FACTORS INCLUDE THE NUMBER OF HOURS WORKED AND THE BREADTH OF ROLES AND RESPONSIBILITIES. FORM 990, PAGE 6, PART VI, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS AND FORM 990 ARE MADE AVAILABLE UPON REQUEST. FORM 990, PART XI, LINE 9 RETURN OF GRANT FUNDS -46,277 RETURN OF GRANT FUNDS 46,277 TY LOUIS CAMPBELL FOUNDATION 1787 ROUTE 6 CARMEL NY 10512 451858390 PROGRAM NY 501C3 7 N/A false false true false false false false false false false false false false false false false false false false false TY LOUIS CAMPBELL FOUNDATION B 50000 FAIR VALUE